Gestational diabetes impacts fetal precursor cell responses with potential consequences for offspring

Area of Science:

• Reproductive Biology
• Stem Cell Biology
• Endocrinology

Background:

• Intrauterine exposure to maternal diabetes is linked to adverse offspring health outcomes.
• Fetal programming is a proposed mechanism for this association.
• The impact of gestational diabetes mellitus (GDM) on fetal stem cells remains unclear.

Purpose of the Study:

• To investigate if GDM imprints on fetal amniotic mesenchymal stem cells (AMSCs).
• To determine if GDM-induced changes in AMSCs correlate with adverse offspring outcomes.
• To explore the molecular mechanisms underlying GDM's effects on fetal development.

Main Methods:

• Prospective case-control study comparing GDM and normal glucose tolerance pregnancies.
• Isolation and characterization of AMSCs and macrophages from amniotic membranes.
• Analysis of AMSC proliferation, osteogenic potential, invasion, and chemotaxis.
• Gene expression analysis of inflammatory and anti-inflammatory markers.
• In vitro studies exposing healthy AMSCs to GDM-related conditions (hyperglycemia, hyperinsulinemia, palmitic acid).

Main Results:

• GDM-derived AMSCs showed impaired proliferation and osteogenic potential but increased invasiveness and chemotaxis.
• Upregulation of inflammatory genes (TNFα, MCP-1, CD40, CTSS) and downregulation of IL-33 in GDM AMSCs.
• Macrophages from GDM mothers exhibited higher MCP-1 expression.
• In vitro studies confirmed these GDM-associated cellular and molecular changes.
• Inflammatory gene expression correlated with maternal insulin sensitivity, BMI, and fetal metabolic parameters.

Conclusions:

• The intrauterine GDM environment can program fetal AMSCs, potentially promoting future metabolic dysfunction in offspring.
• GDM-induced alterations in fetal stem cells may directly contribute to offspring insulin resistance.
• Fetal adaptive programming under GDM conditions has significant implications for long-term offspring health.